News
Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...
More information: Aseno Sakhrie et al, Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection, Vaccines (2025).
More information: An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses, Science Immunology (2025). DOI: 10.1126/sciimmunol.ads1328 ...
Explore the innovative applications of mRNA technologies beyond COVID-19 vaccines. Learn about the potential and future developments in this groundbreaking field.
Our study progresses from the rational design of polyplex micelles to the mechanistic elucidation of mRNA degradation, revealing RNase infiltration—rather than carrier dissociation—as the ...
Two other components making moves today are Lockheed Martin, trading down 1.6%, and Incyte, trading up 4.3% on the day. VIDEO: S&P 500 Movers: MRNA, PLTR The views and opinions expressed herein ...
Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 ...
The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech, which may offer quicker production and greater efficacy than ...
The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...
A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results